Key players operating in the pompe disease therapeutic market include Amicus Therapeutics, Inc., Valerion Therapeutics, LLC, Sanofi S.A., Oxyrane, and Sangamo Therapeutics, Inc.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients